Tom brings over 20 years of experience in working with startups and growth companies in management and finance roles. Tom’s prior roles included serving as Managing Director of a legal services start up in Melbourne for a decade.   He also ran the acquisitions and private equity program for a high-net-worth family office in the US after having started his career in investment banking. Tom has a BSBA from Georgetown University in Washington, DC and earned his MBA from The Anderson School of Management at UCLA.

As Chief Operating Officer, Tom's responsibilities include:

• solidifying collaborative relationships with academic institutions & biotech/pharmaceutical companies covering clinical trials, research to develop novel radiopharmaceuticals, and other commercial ventures;
• managing day-to-day operations and administrative functions at MTIC;
• overseeing accounting and finance requirements of the company; and
• working with our partners to help accelerate the uptake of precision oncology through the establishment of new theranostic centres in Australia and overseas.
  
  

Tom joined MTIC in 2022 and is excited to be part of a great team that will play a leading role in advancing molecular imaging and increasing progress in the emerging medical field of theranostics.

‍